深圳翰宇药业股份有限公司

Chinese peptide pharmaceutical company established in April 2003 in Shenzhen, Guangdong with about 883 million yuan of registered capital, listed on the Shenzhen Stock Exchange ChiNext board in April 2011 under code 300199 and recognised as a national high-tech enterprise. Integrates research, manufacturing and sales of peptide medicines and also makes medical devices, with products spanning peptide formulations, peptide active ingredients, custom peptides, cosmetic peptides, solid oral dosage forms, medical devices, peptide skincare and consumer health lines, and it has added chemical products such as vildagliptin tablets and sitagliptin and metformin tablets to its approvals. Operates through branches and subsidiaries including its Pingshan branch and companies in Wuhan, Hong Kong, Gansu Chengji and Dali.